MedStar Authors catalog › Details for: Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry.
Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry. Journal: American heart journal.Published: 2021; ; ; ; ISSN: 0002-8703.UI/PMID: 34033802.Subject(s): *Anticoagulants/tu [Therapeutic Use] | *Atrial Fibrillation/co [Complications] | *Atrial Fibrillation/dt [Drug Therapy] | *Stroke/pc [Prevention & Control] | Administration, Oral | Aged | Dabigatran/tu [Therapeutic Use] | Female | Humans | Male | Practice Patterns, Physicians' | Pyrazoles/tu [Therapeutic Use] | Pyridines/tu [Therapeutic Use] | Pyridones/tu [Therapeutic Use] | Registries | Risk Factors | Rivaroxaban/tu [Therapeutic Use] | Thiazoles/tu [Therapeutic Use] | Warfarin/tu [Therapeutic Use]Institution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): LetterOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.ahj.2021.04.017 (Click here) Abbreviated citation: Am Heart J. 240:58-62, 2021 10; .Local Holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - 2006.Abstract: Recent data suggest direct oral anticoagulants (DOACs) are as safe and efficacious as warfarin among select patients with valvular heart disease (VHD) and atrial fibrillation (AF). However, real-world treatment patterns of AF stroke prophylaxis in the setting of valvular AF are currently unknown. Accordingly, using the prospective, ambulatory National Cardiovascular Data Registry (NCDR) Practice Innovation and Clinical Excellence (PINNACLE) Registry R, we sought to characterize overall use, temporal trends in use, and the extent of practice-level variation in use of any DOAC and warfarin among patients with valvular AF from January 1, 2013, to March 31, 2019. Copyright (c) 2021. Published by Elsevier Inc.